Kimberly-Clark acquisition of Kenvue gains ISS recommendation

Kimberly-Clark acquisition of Kenvue gains ISS recommendation
Kimberly-Clark gains as Morgan Stanley moves to restricted rating
Exclusive | Kimberly-Clark Nears Roughly $3.5 Billion Sale of International Tissue Business - WSJ
Kimberly-Clark plans +$2B investment in the U.S. to boost manufacturing, distribution
Kimberly-Clark Q1 results flag global currency headwinds, company slashes outlook
32.48BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4943681035
CUSIP
494368129
Sector
Consumer Defensive
Industry
Household & Personal Products
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
20.22
PEG Ratio
1.98
Book Value
4.53
Dividend Share
5.04
Dividend Yield
5.15%
Earnings Share
4.86
Wall Street Target Price
114.86
EPS Estimate Current Year
7.51
EPS Estimate Next Year
7.59
EPS Estimate Current Quarter
1.8118
EPS Estimate Next Quarter
2.049
Most Recent Quarter
-
Revenue TTM
16,446,999,552
Gross Profit TTM
6,136,000,000
EBITDA
3,199,000,064
Profit Margin
12.29%
Return On Assets TTM
9.61%
Return On Equity TTM
126.60%
Revenue Per Share TTM
49.554
Qtly Revenue Growth YOY
-0.60%
Diluted Eps TTM
4.86
Qtly Earnings Growth YOY
11.00%
Trailing PE
20.22
Forward PE
13
Price Sales TTM
1.9828
Price Book MRQ
21.6238
Enterprise Value Revenue
2
Enterprise Value EBITDA
12
85.80
1.93%149.21
0.54%57.70
0.30%17.54
0.06%433.20
-2.79%85.72
-1.48%12.91
-1.07%63.47
-0.83%57.59
-0.45%12.88
-0.23%Curated watchlists where KMB is featured.